Eugenia N. P.
- Country
- Spain
- Department
- Servicio de Medicina Interna
Research Overview
- Evaluation of Antiviral Efficacy and Safety of GSK4004280 and GSK4011499 in Treatment-Naïve Adults with HIV-1 Infection
- A Phase 2b Randomized, Open-Label Active Controlled Study Evaluating the Safety and Efficacy of oral VH4524184 Coadministered with Emtricitabine and Tenofovir Alafenamide in Treatment Naïve Viremic Persons with HIV-1.( INNOVATE Study)
Data & Insights
Has run more than one trial at 13 of 76 partner sites.
Specializations
HIV Treatment Innovation
This investigator specializes in advancing treatment options for HIV-infected patients, with particular focus on exploring novel therapeutic approaches and drug administration methods.
- Long-acting antiretroviral therapy
- Out-of-hospital treatment administration
- Innovative oral therapeutics
The research encompasses evaluation of patient acceptability and treatment feasibility in different clinical settings.
Antiviral Research
The investigator conducts research in antiviral drug development, specifically focusing on new compounds for HIV-1 infection treatment.
- Novel antiviral compounds
- Treatment-naïve patient studies
- Monotherapy evaluation
Their work includes assessment of therapeutic efficacy in various patient populations.
Clinical Implementation
The investigator evaluates treatment implementation strategies with emphasis on patient safety and satisfaction in HIV care.
- Safety and tolerability assessment
- Patient satisfaction studies
- Alternative administration settings
Research focuses on improving accessibility and convenience of HIV treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.